Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

Similar articles for PubMed (Select 22513284)

1.

Positive selection on the gene RNASEL: correlation between patterns of evolution and function.

Jin W, Wu DD, Zhang X, Irwin DM, Zhang YP.

Mol Biol Evol. 2012 Oct;29(10):3161-8. Epub 2012 Apr 17.

2.

Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection.

Summers K, Crespi B.

Infect Genet Evol. 2008 May;8(3):297-301. doi: 10.1016/j.meegid.2008.01.004. Epub 2008 Jan 18.

PMID:
18295551
3.

Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.

Robbins CM, Hernandez W, Ahaghotu C, Bennett J, Hoke G, Mason T, Pettaway CA, Vijayakumar S, Weinrich S, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD, Kittles RA.

Prostate. 2008 Dec 1;68(16):1790-7. doi: 10.1002/pros.20841.

4.

Implications for RNase L in prostate cancer biology.

Silverman RH.

Biochemistry. 2003 Feb 25;42(7):1805-12. Review.

PMID:
12590567
5.

Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.

Fesinmeyer MD, Kwon EM, Fu R, Ostrander EA, Stanford JL.

Prostate. 2011 Oct 1;71(14):1538-47. doi: 10.1002/pros.21370. Epub 2011 Feb 25.

6.

Population genetics of IFIH1: ancient population structure, local selection, and implications for susceptibility to type 1 diabetes.

Fumagalli M, Cagliani R, Riva S, Pozzoli U, Biasin M, Piacentini L, Comi GP, Bresolin N, Clerici M, Sironi M.

Mol Biol Evol. 2010 Nov;27(11):2555-66. doi: 10.1093/molbev/msq141. Epub 2010 Jun 10.

7.

Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.

Rökman A, Ikonen T, Seppälä EH, Nupponen N, Autio V, Mononen N, Bailey-Wilson J, Trent J, Carpten J, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J.

Am J Hum Genet. 2002 May;70(5):1299-304. Epub 2002 Apr 8. Erratum in: Am J Hum Genet. 2004 Dec;75(6):1158. Am J Hum Genet 2002 Jul;71(1):215.

8.

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.

Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Grönberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J.

Nat Genet. 2002 Feb;30(2):181-4. Epub 2002 Jan 22.

PMID:
11799394
9.

Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.

Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, Trent JM, Isaacs WB, Casey G, Silverman RH.

Cancer Res. 2003 Oct 15;63(20):6795-801.

10.

RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.

Shea PR, Ishwad CS, Bunker CH, Patrick AL, Kuller LH, Ferrell RE.

Prostate. 2008 Mar 1;68(4):354-9. doi: 10.1002/pros.20687.

PMID:
18189233
11.

Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.

Wiklund F, Jonsson BA, Brookes AJ, Strömqvist L, Adolfsson J, Emanuelsson M, Adami HO, Augustsson-Bälter K, Grönberg H.

Clin Cancer Res. 2004 Nov 1;10(21):7150-6.

12.

RNASEL -1385G/A polymorphism and cancer risk: a meta-analysis based on 21 case-control studies.

Zhang LF, Mi YY, Qin C, Wang Y, Cao Q, Wei JF, Zhou YJ, Feng NH, Zhang W.

Mol Biol Rep. 2011 Nov;38(8):5099-105. doi: 10.1007/s11033-010-0657-2. Epub 2011 Jan 9.

PMID:
21221811
13.

TRPV6 exhibits unusual patterns of polymorphism and divergence in worldwide populations.

Akey JM, Swanson WJ, Madeoy J, Eberle M, Shriver MD.

Hum Mol Genet. 2006 Jul 1;15(13):2106-13. Epub 2006 May 22.

14.

[G138A polymorphism of the RNASEL gene and its association with the development of prostate cancer. Preliminary study].

Zabala W, Delgado C, Pardo T, Borjas L, Rojas-Atencio A, Reyes F, Quintero JM.

Invest Clin. 2009 Sep;50(3):295-301. Spanish.

PMID:
19961052
15.

Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.

Beuten J, Gelfond JA, Franke JL, Shook S, Johnson-Pais TL, Thompson IM, Leach RJ.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):588-99. doi: 10.1158/1055-9965.EPI-09-0864. Epub 2010 Jan 19.

16.

Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease.

Conrad C, Vianna C, Schultz C, Thal DR, Ghebremedhin E, Lenz J, Braak H, Davies P.

J Neurochem. 2004 Apr;89(1):179-88.

PMID:
15030402
17.

Haplotype structure and evidence for positive selection at the human IL13 locus.

Zhou G, Zhai Y, Dong X, Zhang X, He F, Zhou K, Zhu Y, Wei H, Yao Z, Zhong S, Shen Y, Qiang B, He F.

Mol Biol Evol. 2004 Jan;21(1):29-35. Epub 2003 Aug 29.

18.
19.

Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma.

Noonan-Wheeler FC, Wu W, Roehl KA, Klim A, Haugen J, Suarez BK, Kibel AS.

Prostate. 2006 Jan 1;66(1):49-56.

PMID:
16114055
20.

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.

Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS.

Nat Genet. 2002 Dec;32(4):581-3. Epub 2002 Nov 4.

PMID:
12415269
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk